proteins, parenchymal liver disease, very-lowdensity lipoproteins. 3. With high LCAT low-density lipoproteins (LDL) were normal. The LDL particles found with low LCAT activity were of normal size but of abnormal composition, being triglyceride rich and cholesteryl ester poor. Regardless of LCAT activity LDL were present in normal amounts.
In patients with liver disease there may be striking changes in the plasma concentration of various lipids (Day, Harry & McIntyre, 1979) . Patients with obstructive jaundice, for example, tend to have an increased phospholipid and triglyceride and a marked increase in free cholesterol. The corresponding lipoprotein changes are variable and were found to be closely related to the plasma activity of the enzyme lecithin-cholesterol acyltransferase (LCAT: EC 2.3.1.43). When LCAT activity was normal or high the individual lipoproteins in patients with obstructive jaundice were of normal composition even though they were present in greater amounts than usual. When LCAT activity was low, there were striking abnormalities; abnormal lipoproteins were present in both low-density and high-density lipoprotein fractions (LDL, HDL) and the lipoprotein pattern was remarkably like that found with familial deficiency of LCAT (Agorastos, Fox, Harry & McIntyre, 1978;  Gjone, Norum & Glomset, 1978) .
With parenchymal liver disease plasma lipid changes are quite different. With severe disease there is a fall in total plasma lipids and cholesteryl 575 ester may fall to very low concentrations. There have been relatively few studies on lipoprotein changes in parenchymal liver disease. LCAT activity is often reduced (Calandra, Martin & McIntyre, 197 1) but in contrast to the findings with obstructive jaundice the lipid and lipoprotein abnormalities bear little superficial resemblance to those found in familial LCAT deficiency as plasma lipids tend to be low and lipoprotein-X is usually absent. Even so we believed that a reduction in LCAT activity must affect plasma lipoprotein metabolism in patients with parenchymal liver disease. We therefore made detailed studies on such patients to test the hypothesis that the composition of their lipoproteins would reflect the LCAT activity found in their plasma.
Material and methods
Seventeen patients (seven female, ten male) with parenchymal liver disease of varying severity and with a wide range of plasma cholesteryl ester concentrations were studied. There was no evidence of obstruction to bile ducts or ductules. The diagnosis was confirmed by appropriate investigations including clinical biochemistry and immunology, radiology and liver biopsy (in 16 patients). Twelve patients had alcoholic liver disease, and five had chronic hepatitis and/or cirrhosis not related to alcohol (Table 1) . Autopsy examination of the three patients who died confirmed the absence of any obstruction to the biliary tree. Plasma total lipids and LCAT activity in these patients were compared with the results obtained contemporaneously in 14 normal male subjects (aged 22-38 years, mean 31). Because the separation and analysis of lipoprotein fractions was far more time consuming, the results of more detailed studies on plasma lipoprotein fractions were compared with the results obtained from a different group of nine normal subjects (six male and three female, aged 24-42 years, mean 34), which were presented in our earlier paper (Agorastos et al., 1978) .
Blood was collected after an overnight fast, the disodium salt of ethylenediamine tetra-acetic acid, 2.7 mmol/l, being used as anticoagulant. The plasma was divided into two portions. One was used for liver-function tests and lipoprotein electrophoresis. Ellman's reagent [5,5'-dithiobis-(2-nitrobenzoic acid)] was added to the other (final concentration 1.4 mmol/l) to block LCAT activity (Stokke & Norum, 1971 ). This portion was used for whole plasma lipid estimations, for the preparation of the lipoprotein fractions and for the measurement of LCAT activity. These and other methods for the study of lipoproteins were described in detail by Agorastos et al. (1978) .
To measure LCAT activity we used the method of Stokke & Norum (1971) , which reflects both 75  22  26  M  82  16  53  M  74  14  52  F  149  30  42  F  212  12  43  F  162  9  43  F  >430  8  55  M  280  27  45  F  357  13   21  48  2s  14   1s   43  57  114  32  1 1  24  71  71  90   >zoo   64  77   4 s  42  41  47  46  40  33  39  32  31  33  30  28  27  31  27 (Hatch & Lees, 1968) . Whole lipoprotein fractions were analysed chemically and by immunological reactivity, and were examined by electron microscopy; they were also filtered through a 2.5 cm x 100 cm column of 2% agarose (Bio-Gel A 50 m, 100-200 mesh).
We aimed to produce fractions of lipoproteins with little contamination. We calculated the total lipoprotein within a fraction (expressed per 100 ml of plasma) by adding together the results obtained for individual components of the lipoproteins, all of which were corrected to 100 ml of plasma, without correction for losses. The recovery of the various subfractions (calculated by comparing the sum of their lipid contents with total plasma lipid) was both low (mean recovery 86%) and variable (77-99%), and so the results must be treated as crude estimates. VLDL (d < 1.006), LDL (1.006-1.063) and Lipoprotein fractions were tested for immunoreactivity with commercially available antisera to p-and a-lipoprotein (Hoechst). Lipoprotein-X was detected with an immunoelectrophoretic method (Seidel, Wieland & Ruppert, 1973) , by using an antiserum against lipoprotein-X (Hoechst).
Column fractions and centrifugal preparations were examined by using negative staining techniques and with a Philips 300 electron microscope.
Results

Plasma LCAT activity
The plasma LCAT activity of 14 normal male subjects ranged from 50 to 80 nmol h-l ml-l with a mean of 66 nmol h-l ml-'.
The plasma LCAT activity in our patients ranged from 5.3 to 169 nmol h-l ml-l. On the basis of LCAT activity patients were arbitrarily divided into three groups: those with high (>64 nmol h-l ml-l, mean 99, intermediate (17-37 nmol h-l ml-l, mean 26) and low (5-3-12 nmol h-l ml-l, mean 7.7) LCAT activity. There was a significant correlation between LCAT activity and plasma albumin (r = 0.79, P < 0.001) and a negative correlation with total bilirubin (rs = -0.92, P @ 0.001; Spearman's rank correlation test) but no significant correlation was found with other liver-function tests.
Total plasma lipids
There was great variation in the plasma lipid conchtrations found in our patients ( Table 2 ) . In the high LCAT-activity group the total lipid was significantly higher than in the other two groups, but the proportions of individual plasma lipids (expressed as percentages of total lipid) were close to those of normal subjects.
Patients with low LCAT activity had significantly lower total plasma lipids than the other two groups ( P < 0.05). Subjects with intermediate LCAT activity had a mean value similar to that of the comparison group. In the low LCAT-activity patients the relative proportions of various lipids were grossly abnormal; there was an elevation of free cholesterol and of triglyceride, and a low ester :free ratio. Some patients with intermediate LCAT activity showed almost normal proportions of lipids; others had striking abnormalities.
In all three groups the mean free cholesterol concentration was higher than in the comparison subjects. Total plasma triglycerides were in the normal range, with no significant difference between the groups.
There was a significant correlation between LCAT activity and plasma cholesteryl ester concentrations (r = 0.71, P < 0.01) and between LCAT activity and the ester:free ratio ( r = 0.53, P < 0.05).
Individual lipoprotein fractions
Very-low-density lipoproteiris. AU patients were found to have VLDL (d < 1.006) when it was isolated by preparative ultracentrifugation; but a pre-p band (usually indicative of VLDL) was visible only in patients with high LCAT activity and in three of the seven patients with intermediate LCAT activity. The VLDL from high LCATactivity patients had a normal composition (Table  3 ). In the intermediate LCAT-activity group the composition was variable. The VLDL from low LCAT-activity subjects was abnormal, having a high protein and triglyceride, and a low phospholipid, free cholesterol and cholesteryl ester. The amounts of VLDL recovered in this group of patients were very small and we could not be certain of the accuracy of our chemical measurements at such low concentrations. There was a significant correlation between LCAT activity and our crude estimate of the mass of total VLDL (r = 0.87, P < 0.001). Regardless of LCAT activity there was never more than one peak found on column chromatography and no obvious abnormalities were seen on electron microscopy. There was a significant correlation between total VLDL and plasma albumin ( r = 0.79, P < 0.001) and a negative correlation with plasma bilirubin (r = Low-density lipoproteins. LDL ( d < 1.006-1.063) from patients with high LCAT activity was normal in composition (Table 4 ) and morphology. LDL from low LCAT-activity patients was abnormal; the proportions of free cholesterol and triglyceride were elevated and there was less cholesteryl ester. The composition of LDL from the Normal (9) 8.5 (8.1-9.9) Patients High LCAT (5) 8-9 (6.7-1 1.4) Intermediate LCAT (7) 11.4 (8-5-13.7) Low LCAT (5) 14 intermediate LCAT-activity group was variable but the mean values for the relative proportions were between the mean values for the high and low LCAT-activity groups. With agarose column chromatography only one peak was seen in the LDL fraction regardless of LCAT activity, and this material reacted with antiserum to /%lipoprotein. On electron microscopy only normal sized particles (N-20 nm) were seen, except in one patient with low LCAT activity who showed a small amount of lipoprotein-X. The composition of material found in the single peak after column chromatography was virtually identical with the composition of the whole LDL fraction before chromatography. There was a significant correlation between LCAT activity and the proportion of LDL cholesterol present as cholesteryl ester (r = 0.59, P < 0.01) and between LCAT activity and the cholesteryl ester :triglyceride ratio found in LDL (r = 0.78, P < 0.001). With a fall in LCAT activity relatively more plasma triglyceride was found in LDL than in VLDL; the ratio triglyceride (mg) contained in VLDL/triglyceride (mg) contained in LDL was significantly correlated with LCAT activity (r = 0.89, P < 0.001).
The total amounts of LDL found in all three groups were similar; the mean values were close to those found in the nine normal subjects in the comparison group although the range in each case was wider.
High-density lipoproteins. HDL (d 1.063-1.21) was isolated by ultracentrifugation from all patients but an a-lipoprotein band was visible on electrophoresis only in patients with high LCAT activity, and in six patients with intermediate LCAT activity (including the three who showed a pre-P band). The total amount of HDL in the high LCAT-activity group was greater than in our intermediate subjects (Table 5) .
It eluted as one major peak after agarose column chromatography and looked like normal HDL on electron microscopy. HDL from low LCATactivity patients and from some of those with intermediate LCAT were poor in protein and cholesteryl esters but rich in free cholesterol, phospholipid and triglyceride. Column chromatography usually revealed only a single peak. In all the low LCAT-activity patients and in the one patient in the intermediate group who had no alipoprotein band this peak eluted earlier than normal HDL, and on electron microscopy large particles (diameter N_ 20 nm) were seen which formed stacked discs with a periodicity of 5 nm.
Discussion
Our results support the hypothesis that plasma lipid and lipoprotein changes in patients with parenchymal liver disease reflect the LCAT activity found in plasma. In patients with high LCAT activity total plasma lipids were elevated but there were no other obvious changes. The cholesteryl ester :free cholesterol ratio was virtually normal and lipoprotein electrophoresis revealed a normal pattern. With low LCAT activity changes were marked. Total plasma lipids were low, due mainly to a fall in cholesteryl ester. Free cholesterol was elevated and the ester:free ratio was markedly reduced. The phospholipid concentration was also low but the mean plasma triglyceride was high although in the normal range. The plasma lipid changes in the intermediate group were similar to those found in the high LCAT-activity group and in our comparison subjects, but the ester :free ratio was lower and the mean free cholesterol was higher than one would have expected in normal subjects. In the low LCAT-activity group and in four of the intermediate group the pre-P band was absent on lipoprotein electrophoresis and in the low LCAT group the aband was also lost.
Very-low-density lipoproteins
In our previous study on obstructive jaundice the absence of a pre-P band on lipoprotein electrophoresis in patients with low LCAT activities did not mean that there was a corresponding reduction in VLDL; after ultracentrifugation relatively large amounts of VLDL were found but it ran with / 3 and not pre-P mobility (Agorastos et al., 1978) . In our patients with parenchymal liver disease, however, the absence of a pre-P band was associated with a striking reduction in the plasma concentration of VLDL. Its composition seemed to be grossly abnormal but in many cases the amounts recovered were so low that we consider the results of our chemical analysis to be unreliable. The amount of VLDL in plasma correlated with plasma LCAT activity but it is unlikely that low concentrations were the consequence of low LCAT activity as VLDL concentrations are normal in familial LCAT deficiency and in patients with obstructive jaundice and low plasma LCAT activity. It seems likely that the fall in VLDL is due to reduced secretion from the damaged liver; VLDL concentrations were correlated with plasma albumin and inversely correlated with plasma bilirubin.
High-density lipoproteins
An a-lipoprotein band was visible on electrophoresis in patients with high plasma LCAT activity and in six out of seven patients with intermediate LCAT activities. The a-band was absent in patients with low LCAT activities but HDL could be isolated from all three groups by ultracentrifugation. The mean concentrations in each group were proportional to the mean plasma LCAT activities but surprisingly the correlation between plasma LCAT activity and HDL concentrations was not statistically significant. We found a significant relationship in patients with obstructive jaundice (Agorastos et al., 1978) and other workers have found a significant correlation in normal subjects and in patients with parenchymal liver disease (Blomhoff, 1974; Blomhoff et al., 1974) .
In patients with high plasma LCAT activities only one HDL peak was seen on column chromatography and its composition was virtually normal. With low LCAT activity, and in some patients with intermediate LCAT activity, we found changes similar to those found in our patients with obstructive jaundice. The HDL were low in cholesteryl ester and protein and rich in triglyceride, phospholipid and free cholesterol but on column chromatography only one broad peak was seen.
In six patients electron microscopy of the HDL fraction revealed stacked discs. These particles were similar to those seen in obstructive jaundice (Utermann, Schoenborn, Langer & Dieker, 1972; and in familial LCAT deficiency (Norum, Glomset, Nichols & Forte, 1971) . Hamilton, Williams, Fielding & Have1 (1976) presented evidence that stacked discs are the form in which HDL is released from liver into plasma, but recently Chajek & Eisenberg (1978) postulated that stacked discs may originate within plasma as a result of the catabolism of VLDL. Regardless of the mechanisms by which stacked discs appear in the plasma of patients with parenchymal liver disease, it seems likely that they accumulate only if LCAT activity is low. Certainly the stacked discs found in familial LCAT deficiency and obstructive jaundice are converted into spherical 'HDL' particles by the action of LCAT ). It appears that they change shape because non-polar cholesteryl ester enters the core of the disc to produce a spherical particle.
Lo w-density lipoproteins
The results of our studies on the LDL fraction in parenchymal liver disease were of particular interest. Characteristically only one peak was found on column chromatography regardless of the plasma LCAT activity, and it was composed of normal-sized LDL particles. In only one patient, with low LCAT activity, was a small amount of lipoprotein-X seen on electron microscopy. These findings were quite different from those of obstructive jaundice, as plasma from obstructed patients with low LCAT activity could contain three types of LDL (Agorastos et al., 1978) . With parenchymal liver disease and high LCAT activity LDL were of normal composition. In patients with low and intermediate LCAT activity the LDL were rich in triglyceride and free cholesterol, and were cholesteryl ester poor. Their abnormal composition was therefore similar to that of the normal-sized LDL particles in obstructive jaundice and, as in that condition, the degree of abnormality seemed to be closely related to the LCAT activity of plasma.
We were surprised to find that the mean concentration of LDL was normal in patients with parenchymal liver disease, regardless of plasma LCAT activity or the apparent severity of the liver disease. Because the plasma cholesteryl ester was very low in several of our patients and because LDL normally carry most of the cholesteryl ester in plasma we had expected that LDL concentrations would be reduced. However, Pierce & Gofman (1951) found only minor changes in plasma LDL concentration in cirrhotic patients and in a later study Pierce, Kimmell & Burns (1954) found significant elevation of LDL in patients with viral hepatitis. (Unfortunately these authors presented few clinical or biochemical data and their results are dimcult to interpret in retro-40 spect.) The explanation for the normal amount of LDL in the presence of a reduced plasma cholesteryl ester was provided by our studies in patients with obstructive jaundice and confirmed in this study. As LCAT activity falls the cholesteryl ester normally found in the core of spherical 20 nm LDL particles is replaced by triglyceride, without apparent change in the size, shape or concentration of the particles. Thus the cholesteryl ester content of plasma (and of the LDL fraction) falls while LDL triglyceride rises. This explains our earlier observations on the sequential changes occurring in viral hepatitis (Pearson, Lipoprotein-X, which is rich in free cholesterol and phospholipid, was present in most of our patients with obstructive jaundice and reduced LCAT activity, and it is found in patients with familial LCAT deficiency. However, it was present, in small amounts, in only one of our patients with parenchymal liver disease. This suggests that the presence of lipoprotein-X is not solely dependent on a reduction of plasma LCAT activity. It has been suggested that lipoprotein-X is formed in familial LCAT deficiency because the enzyme is not available to handle excess phospholipid and free cholesterol derived from the surface coat of chylomicrons and VLDL (Glomset, Norum, Nichols, Forte, King, Albers, Mitchell, Applegate & Gjone, 1974) . In obstructive jaundice, on the other hand, we suggested that biliary regurgitation causes a rise in plasma phospholipid and free cholesterol and that lipoprotein-X appears if LCAT activity is insufficient to cope with this extra lipid (Agorastos  et al., 1978) . In parenchymal liver disease without cholestasis there would be no excess lipid derived from biliary regurgitation and the production of both chylomicrons and VLDL is almost certainly reduced. Under these circumstances it would be surprising if lipoprotein-X accumulated even if the LCAT activity was low.
It is currently believed that LDL is formed as a result of the catabolism of VLDL in plasma (Eisenberg & Levy, 1975) . VLDL concentrations were low in our patients with severe parenchymal liver disease, presumably because the damaged liver was incapable of synthesizing and secreting this lipoprotein in normal amounts, and our finding of normal LDL concentrations was therefore surprising. The reason for this is not clear but reduced catabolism of LDL is a possibility. The available evidence on the importance of the liver in degrading LDL is conflicting. If the liver is an important site of LDL catabolism our results could be explained by reduced hepatic uptake of LDL in the presence of liver damage. Alternatively, peripheral LDL uptake may be impaired because the circulating LDL has an abnormal composition.
